Abbas Iqbal, Abubakar Afzal, Zaib Un Nisa. Comments on: Efficacy and Safety Assessment of Upadacitinib for SAPHO Syndrome: A Retrospective Study of 35 Patients. // International Journal of Rheumatic Diseases. – 2026. – DOI: 10.1111/1756-185x.70965. – URL: https://onlinelibrary.wiley.com/doi/10.1111/1756-185x.70965?af=R
Abbas Iqbal, Abubakar Afzal, & Zaib Un Nisa (2026). Comments on: Efficacy and Safety Assessment of Upadacitinib for SAPHO Syndrome: A Retrospective Study of 35 Patients. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70965
Abbas Iqbal, et al. “Comments on: Efficacy and Safety Assessment of Upadacitinib for SAPHO Syndrome: A Retrospective Study of 35 Patients.” International Journal of Rheumatic Diseases, 2026. doi:10.1111/1756-185x.70965.
@article{Iqbal2026,
title = {Comments on: Efficacy and Safety Assessment of Upadacitinib for SAPHO Syndrome: A Retrospective Study of 35 Patients},
author = {Iqbal, Abbas and Afzal, Abubakar and Nisa, Zaib Un},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
doi = {10.1111/1756-185x.70965},
url = {https://onlinelibrary.wiley.com/doi/10.1111/1756-185x.70965?af=R}
}